Cuprina Holdings (Cayman) Limited (CUPR)

Market Cap	6.44M -93.2%
Revenue (ttm)	38,791 +3.3%
Net Income	-3.63M
EPS	-1.42
Shares Out	2.68M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	296,549
Open	2.460
Previous Close	3.300
Day's Range	2.209 - 2.700
52-Week Range	1.760 - 76.000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 27, 2026

About CUPR

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste; and products using m...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Apr 10, 2025
• Employees: 10
• Stock Exchange: NASDAQ
• Ticker Symbol: CUPR
• Website: https://www.cuprina.com.sg

Financial Performance

In 2025, CUPR's revenue was 49,894, an increase of 3.26% compared to the previous year's 48,321. Losses were -4.67 million, 199.5% more than in 2024.

Financial numbers in SGD